{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/UDR/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-14T23:54:36.058Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":8783,"canonical_name":"UDR, Inc.","cik":"0000074208","uei":null,"lei":null,"duns":null,"ticker":"UDR"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":7},"count":7,"timeline":[{"ts":"2026-09-09","kind":"sec.filing","form_type":"8-K","title":"8-K — UDR, Inc. — 2026-09-09","url_slug":"/sec/cik-0000074208/8-k/0000074208-26-000077","accession_number":"0000074208-26-000077","importance":35},{"ts":"2026-07-28","kind":"sec.filing","form_type":"10-Q","title":"10-Q — UDR, Inc. — 2026-07-28","url_slug":"/sec/cik-0000074208/10-q/0000074208-26-000073","accession_number":"0000074208-26-000073","importance":45},{"ts":"2026-07-27","kind":"sec.filing","form_type":"8-K","title":"8-K — UDR, Inc. — 2026-07-27","url_slug":"/sec/cik-0000074208/8-k/0000074208-26-000070","accession_number":"0000074208-26-000070","importance":35},{"ts":"2026-07-23","kind":"sec.insider.f","reporter":"Bragg David D.","title":"SVP - Chief Financial Officer","shares":2134,"price_per_share":39.48,"usd_value":84250,"security_title":"Common Stock","importance":15.08425032},{"ts":"2026-07-21","kind":"sec.filing","form_type":"424B3","title":"424B3 — UDR, Inc. — 2026-07-21","url_slug":"/sec/cik-0000074208/424b3/0000074208-26-000066","accession_number":"0000074208-26-000066","importance":30},{"ts":"2026-06-05","kind":"sec.form144","reporter":"Thomas W Toomey","title":"Officer","shares":80000,"usd_value":3136000,"security_title":"Common","approx_sale_date":"2026-06-05","accession_number":"0001628280-26-041133","importance":40.6272},{"ts":"2026-06-05","kind":"sec.insider.s","reporter":"TOOMEY THOMAS W","title":"Chairman, President and CEO","shares":80000,"price_per_share":39.2501,"usd_value":3140008,"security_title":"Common Stock","importance":38.140008}]}